Search

Search Constraints

You searched for: Author/Creator Livingston, John Andrew

Search Results

2. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Issue 9 (September 2022)

4. Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile. Issue 1 (17th June 2019)